BRCA2 and breast cancer: Given that, we reanalyzed the WES datasets including 10 familial non-BRCA1/BRCA2 BC pedigrees (Gracia-Aznarez et al., 2013; Hilbers et al., 2013), manually evaluated variants as recommended (Hampel et al., 2015), and performed data mining on pan-cancer datasets.